FSK vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 27, 2026

FSK

35.8
AI Score
VS
CNS Wins

CNS

57.6
AI Score

Investment Advisor Scores

FSK

36score
Recommendation
SELL

CNS

58score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric FSK CNS Winner
Forward P/E 6.4641 22.5734 FSK
PEG Ratio 3.2724 2.017 CNS
Revenue Growth -24.0% 12.2% CNS
Earnings Growth 33.8% 31.9% FSK
Tradestie Score 35.8/100 57.6/100 CNS
Profit Margin -38.6% 28.8% CNS
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD CNS

Relative Price Performance (Last 90 Days)

FSK 1M: +6.3% · 3M: -4.0% CNS 1M: +7.7% · 3M: +22.1%

Current Technical Phase

FSK

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.1 · Price: $11.09

CNS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.5% over 20 days), RSI 66

RSI (14): 66.0 · Price: $84.63

Fundamentals Snapshot

Metric FSK CNS
Market Cap
Forward P/E 7.2 21.8
Trailing P/E 25.3
Revenue (TTM)
Revenue Growth -0.2% 0.1%
Gross Margin 1.0% 0.5%
Operating Margin 0.7% 0.3%
EPS -1.96 3.25
Dividend Yield 0.22% 0.03%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.